Evidence map›Paper›PMID 35527779›Full record

ArticleOncology letters2022

6-Gingerol suppresses cell viability, migration and invasion via inhibiting EMT, and inducing autophagy and ferroptosis in LPS-stimulated and LPS-unstimulated prostate cancer cells.

Chi-Ming Liu, Lijie An, Zhengping Wu, Ai-Jun Ouyang, Mengqiao Su, Zichen Shao, Yi Lin, Xiaoyu Liu, Yinjie Jiang

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Effect of ginger, chamomile, and green tea extracts on prostate cancer cells.Journal, genetic engineering & biotechnology · 2024
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Autophagy Regulators in Cancer.International journal of molecular sciences · 2023
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Chi-Ming LiuSchool of Medicine, Yichun University, Yichun, Jiangxi 336000, P.R. China.
Lijie AnSchool of Medicine, Yichun University, Yichun, Jiangxi 336000, P.R. China.
Zhengping WuSchool of Aesthetic Medicine, Yichun University, Yichun, Jiangxi 336000, P.R. China.
Ai-Jun OuyangDepartment of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China.
Mengqiao SuSchool of Medicine, Yichun University, Yichun, Jiangxi 336000, P.R. China.
Zichen ShaoSchool of Medicine, Yichun University, Yichun, Jiangxi 336000, P.R. China.
Yi LinSchool of Aesthetic Medicine, Yichun University, Yichun, Jiangxi 336000, P.R. China.
Xiaoyu LiuSchool of Aesthetic Medicine, Yichun University, Yichun, Jiangxi 336000, P.R. China.
Yinjie JiangSchool of Medicine, Yichun University, Yichun, Jiangxi 336000, P.R. China.
Yichun University · CNFirst Affiliated Hospital of Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

6-Gingerol is a bioactive compound isolated from

Indexed as

6-gingerolautophagyepithelial-mesenchymal transitionferroptosisprostate cancer

Identifiers

PMID35527779
PMCPMC9073581
OpenAlexW4224868033

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.